Skip to content
Keeping Current CME cover art

All Episodes

Keeping Current CME — 785 episodes · page 7 of 8

#
Title
601

Ask Your Mentor: Depression Screening via Telemedicine

602

Through the Looking Glass: What Is the View on Eosinophilic Gastrointestinal Diseases?

603

Cases From the Clinic: A Perspective on Managing Schizophrenia in Community Practice

604

A 20/20 Perspective on Barrier Repair and Skin Care in Pediatric and Primary Care

605

The Science Behind the First COVID-19 Vaccines

606

Improving MRI Workflow: The Value of Abbreviated Protocols

607

The Nurse View on BTK Inhibitors: Optimizing Your Care of Patients with CLL

608

BTK Inhibitors in CLL: Summer Data Updates and Expert Perspectives

609

Communication Conundrums: Tips and Techniques for Addressing Questions About HPV Immunization

610

Clinical Pearls for Pharmacists: BTK Inhibitors for the Treatment of CLL

611

State of Care: A Closer Look at OAB in LTC Facilities

612

The Role of Retinoid Receptor Signaling in Acne Pathology, Pathophysiology, and Treatment

613

2021 Data Blitz From the American Headache Society Annual Scientific Meeting

614

Recent Updates on the Mutational and Treatment Landscape of Advanced GIST

615

SARS-CoV-2 Variants and Monoclonal Antibodies: What Do We Know?

616

Monoclonal Antibodies: Looking Beyond COVID-19

617

Out of Control: Perspectives on Worsening Trends in Blood Pressure Control Rates

618

Call to Action in the Hospital: Potassium Management in the Real World

619

Antibodies and Vaccines: Why We Still Need Post-Exposure Prophylaxis

620

Patient Questions and Expert Answers for Healthy Skin of Color

621

The Emerging Receptor Science in the Management of Schizophrenia

622

Emerging Practice Strategies for PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma

623

Barriers to Access and Connecting People to Care

624

Early Diagnosis of PAH: The Latest Tools and Approaches

625

Postexposure Prophylaxis for COVID-19 Prevention: Where Do We Stand?

626

Navigating the Management of Triple-Negative Breast Cancer: Immunotherapy Considerations

627

Expert Perspective Series: Tips for Addressing Patients FAQs About COVID-19 Vaccines

628

Expanding Targetable Treatment in Thyroid Cancer: NTRK Fusions

629

Diagnostic Pearls in EGIDs Beyond EoE

630

Evidence Update and Practical Perspectives: Monoclonal Antibodies for COVID-19 Treatment

631

Vaccines vs Monoclonal Antibodies for COVID-19: Complementary Approaches to Tackling the Pandemic

632

Expert Exchange: The Why, When, and How of "On-Demand" Therapies for Parkinson Disease

633

Bipolar Depression: Putting the Patient at the Center of Care

634

Year in Review: Perspectives on JAK Inhibitors for Atopic Dermatitis

635

Mirror, Mirror on the Wall: The Perception of Acne

636

Ask the Experts: What Practical Information Do I Need to Know About Cannabinoids?

637

Everything You Need to Know About ICIs in Gynecologic Cancers

638

The Role of Antibiotic Stewardship in the Management of Rosacea

639

Challenges and Opportunities in the Use of Monoclonal Antibody Therapy for COVID-19

640

Emerging Treatments for Diabetic Macular Edema: New Data

641

Neutralizing the Virus: A Focus on SARS-CoV-2–Specific Monoclonal Antibodies

642

Gene Testing for Limb-Girdle Muscular Dystrophy: What, When, How

643

Optimizing Access to Monoclonal Antibodies for COVID-19: US Perspective

644

Understanding the Potential of Antibodies for COVID-19

645

New Horizons in Neovascular Age-Related Macular Degeneration: Latest Data and Expert Thoughts on Emerging Therapies

646

Fundamentals of Eosinophilic Gastrointestinal Diseases: What You Need to Know

647

Practical Management of Prostacyclin Pathway Therapy: A Focus on the Patient Experience

648

Potassium and Acid Regulation: Clinical Implications for Clinicians

649

COVID-19 Evidence Updates: Optimizing Care During the Evolving Pandemic: Vaccines

650

Expert Perspectives in Best Practices in Osteoarthritis Care

651

Essential Updates in GI Immunotherapy: HCC and Esophageal Cancers

652

Timing Is of the Essence for Migraine Prevention

653

rtCGM in Primary Care: Quick Tips for the Busy Clinician

654

Treatment Algorithms in Melanoma: Evaluating Where We Are and Where We Are Headed

655

Antiplatelet Therapy to Prevent Stroke: Where Does Aspirin Fit In?

656

Key Considerations for Managing Patients With Bipolar Disorder: What the PCP Needs to Know

657

Principles and Practicalities: The Logistics of Bringing NAbs Into Patient Care

658

Special Populations and Immune Checkpoint Inhibitors: Are They Safe?

659

A Clinician's Guide to Improve Early Detection and Treatment of Homozygous Familial Hypercholesterolemia (HoFH)

660

Updates and Advances: The Latest Data on Neutralizing the COVID-19 Pandemic

661

Updates in the Management of Treatment-Naive CLL

662

Depression Clinic: Can You Manage These Patients?

663

A Journey Into the Patient Experience of Frequent Migraine: Lessons for the Clinician

664

Expanding the Pharmacist's Role in rtCGM Use and Education in Practice

665

From Women/For Women: Perspectives in HIV Care

666

Personalizing Progressive Metastatic CRC Treatment

667

Choosing PAH Treatment With Short- and Long-Term Goals in Mind

668

Early Identification and Management of Infants With Growth Failure

669

Back to Basics With Cannabinoids: Endocannabinoids vs Phytocannabinoids

670

Updates in the Treatment of Multiply Relapsed/Refractory Multiple Myeloma

671

Assessing Current and Emerging Options for the Management of Peripheral T-Cell Lymphoma

672

Updates on Immune Modulators in Lung Cancer: Have We Met the Need?

673

COVID-19 Evidence Updates: Optimizing Care During the Evolving Pandemic: Treatment and Vaccines

674

Targeted Alpha Therapies in Prostate Cancer

675

Strategies for Ending the Pandemic: A Multipronged Approach

676

Shifting the Balance Between the Immune System and Cancer: Moving Beyond the PD-1/PD-L1 Axis

677

Best Practices for Assessing and Managing Side Effects of CLL

678

Involving Patients With Relapsed/Refractory Multiple Myeloma in Decision Making

679

Treatment Advances in NTRK Gene Fusion-Positive Sarcoma: What Do You Need to Know?

680

Updates in Atopic Dermatitis from the European Allergy Meeting

681

Stories From the Field: Rapid Diagnostic Testing for Meningitis in the ED

682

On the Frontlines: Testing for SARS-CoV-2

683

Expert Perspectives on the Management of Advanced Thyroid Cancer: What's New?

684

New Treatment Options for High-Risk COVID-19 Patients With Mild to Moderate Disease

685

Treatment of Major Depressive Disorder: A Foundational Perspective

686

COVID-19 Evidence Updates: Optimizing Care During the Evolving Pandemic: Testing for SARS-CoV-2

687

Stories From the Field: Updates on Syndromic Testing for RTIs and COVID-19

688

Prostate Cancer: A PSA on nmCRPC Updates

689

Challenging Cases in NAFLD and NASH: Diagnosis

690

Case Studies in Children With Hemophilia A: Leveraging PK for Use With SHL FVIII Replacement Therapy

691

Foundations for Measurement-Based Care for MDD

692

Patient Selection for Aspirin Therapy: Implications for Primary Care

693

Case Discussions in the Early Recognition of Duchenne Muscular Dystrophy (DMD)

694

Compass to Topical Antioxidants in Cosmeceuticals: Why, What, When, and How?

695

Putting it Into (Best) Practice: Diagnostic Challenges and Opportunities in Pneumonia

696

360-Degree Management of CKD Patients to Delay/Prevent Progression to ESRD

697

Stories From the Field: Syndromic Testing for Meningitis/Encephalitis

698

Pathways to Prevention: Optimizing Influenza Vaccination in the Era of COVID-19

699

Stories from the Field: Syndromic Testing for Respiratory Tract Infections in the COVID Era

700

Diet, Loop Diuretics, and/or Potassium Binders to Manage Hyperkalemia?